Efficacy and Safety of Habitual Consumption of a Food Supplement Containing Miraculin in Malnourished Cancer Patients: The CLINMIR Pilot Study.

Taking the latter into account, after three months of intervention, all patients showed a trend to decrease in levels of palmitic and stearic acid from the fatty acid profile of erythrocytes ( p = 0.068), particularly in DMB patients (% change standard dose: −13.2 ± 44.0/−7.9 ± 17.5; high dose: −7.9 ± 29.1/−11.9 ± 19.7; placebo: 3.6 ± 35.9/−1.0 ± 42.3) ( Table 6 , Figure 5 ).

also in 53,322 other papers